iSpine Research & Therapeutics is the dedicated research division of iSpine Clinics. Our team is involved in multiple clinical trials and research studies in order to investigate causes of chronic pain, and to develop cutting edge technologies and treatments for chronic pain, which will ultimately provide better outcomes for patients worldwide. Through our involvement, our physicians are able to offer treatment options not yet available to the public at-large.
We partner with leading medical device companies and industry chronic pain experts to develop more effective treatment options and study these options in a safe, controlled manner within our clinical practice.
Our Team
James B Parmele, MD
Jason S Wolff, MD
Dustin Ward, MD
Rano Faltas, MD
Ron Boeding, MD
Current Clinical Trials & Research Studies
At iSpine Research & Therapeutics, we are committed to discovering innovative solutions for the treatment of chronic pain. Through collaboration with industry partners and leading clinical experts, we are able to offer the newest, cutting-edge technologies that may not be available to all clinical practices. We take significant time in the selection of our research efforts and strive to offer our patients the best chronic pain solutions in the safest manner possible.
iSpine Research & Therapeutics is involved in several studies investigating novel devices and treatment options for chronic neck, back, and/or limb pain. When available, please review the study specifics below and contact us to inquire if you would be an appropriate study candidate.
Chronic Migraines (RELIEV-CM2 Study)
Enrollment: OPEN
iSpine Clinics, in conjunction with ShiraTronics, is studying an investigational non-drug treatment for migraine sufferers experiencing 15 or more headache days a month. The study is evaluating the ShiraTronics System, a small device placed under the skin that delivers mild electrical pulses to nerves associated with migraine pain. If you are living with migraine and have not received long-term relief from other treatments, you may qualify for the Reliev-CM2 Clinical Study.
